Modulation of Appetite Signaling Through Enterohormone Stimulation by DNF-10

This is a pilot, proof-of-concept, exploratory, randomized, double-blind, placebo-controlled crossover study. The study will be conducted in 50 healthy volunteers with a body mass index (BMI) between 18.5 and 29.9 kg/m². The objective is to comprehensively evaluate the potential of DNF-10 to modulate appetite through the regulation of enteroendocrine hormones and to determine its relevance in human physiology.

NCT Number	NCT07621393
Lead Sponsor	Fytexia Collaborators: Centros de Investigación de Nutrición y Salud
Conditions	Healthy Adult
Enrollment	50 participants
Start Date	2026-05-12
Primary Completion	2026-09 (estimated)
Study Completion	2026-09 (estimated)
Updated on ClinicalTrials.gov	2026-06-04